First Time Loading...

P3 Health Partners Inc
NASDAQ:PIII

Watchlist Manager
P3 Health Partners Inc Logo
P3 Health Partners Inc
NASDAQ:PIII
Watchlist
Price: 0.5998 USD 3.77% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

PIII Price Targets Summary
P3 Health Partners Inc

Wall Street analysts forecast PIII stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PIII is 2.856 USD with a low forecast of 0.909 USD and a high forecast of 4.725 USD.

PIII Lowest Forecast
Wall Street Target
0.909 USD
52% Upside
PIII Average Forecast
Wall Street Target
2.856 USD
376% Upside
PIII Highest Forecast
Wall Street Target
4.725 USD
688% Upside
Lowest
Price Target
0.909 USD
52% Upside
Average
Price Target
2.856 USD
376% Upside
Highest
Price Target
4.725 USD
688% Upside
P3 Health Partners Inc Competitors:
Price Targets
4694
BML Inc
9% Upside
E
1846
Euroeyes International Eye Clinic Ltd
97% Upside
E
6099
Elan Corp
11% Upside
H
AIDX
Healwell Al Inc
14% Downside
4694
BML Inc
9% Upside
E
1846
Euroeyes International Eye Clinic Ltd
97% Upside
E
6099
Elan Corp
11% Upside
H
AIDX
Healwell Al Inc
14% Downside
E
EHAB
Enhabit Inc
12% Upside
T
5G3
Talkmed Group Ltd
61% Upside
HLA
Healthia Ltd
0% Upside
PRVA
Privia Health Group Inc
53% Upside

Revenue
Forecast

Revenue Estimate
P3 Health Partners Inc

For the last 4 years the compound annual growth rate for P3 Health Partners Inc's revenue is 72%. The projected CAGR for the next 2 years is 17%.

72%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
P3 Health Partners Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
26%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
P3 Health Partners Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss
What are analyst estimates?

See Also

Summary
PIII intrinsic value, competitors valuation, and company profile.
DCF Valuation
PIII stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PIII stock valuation using valuation multiples.
Wall Street Estimates
PIII price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PIII stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PIII's stock price target?
Price Target
2.856 USD

According to Wall Street analysts, the average 1-year price target for PIII is 2.856 USD with a low forecast of 0.909 USD and a high forecast of 4.725 USD.

What is P3 Health Partners Inc's Revenue forecast?
Projected CAGR
17%

For the last 4 years the compound annual growth rate for P3 Health Partners Inc's revenue is 72%. The projected CAGR for the next 2 years is 17%.

ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.